登录

Funing Technology Announces Closing of $1.4M Funding by Strategic Investor Shengjitang

Mailman 2019-12-25 20:12

圣济堂
http://www.gzcth.net/
企业数据由 动脉橙 提供支持
糖尿病药品研发商 | IPO | 运营中
中国-贵州
2018-05-29
中国长城资产
查看

On December 14, 2019, Shanghai-based Funing Information Technology Co., Ltd. ("Funing Technology") has got tens of millions of yuan (US$1.4 million) in strategic financing from Shengjitang, a listed pharmaceutical company, and built a strategic partnership with the latter. After the completion of this round financing, Funing Technology’s valuation will reach 200 million.


Funing Technology focuses on the application of information technology in the field of medicine, medical services and healthcare. It uses the Internet and big data technology to provide online services such as diagnosis, drug purchase, and health management. The company reduces the time of medical treatment, optimize the supply chain, and provide users with a complete solution for medical treatment and drug purchase.


Through the integration of the medical software, the ERP system, and the modern logistics visual system, Funing Technology has built up an Internet ecosystem of big health prescription and online pharmacy in the mode of B2B, B2C and O2O. Xia Guilang, chairman of Funing Technology, said that the company's business is based on its self-developed product supply chain system to achieve the goal of reducing intermediate processes, lowering drug prices and serving the public.


Shengjitang focuses on the manufacturing of chemical products and medical drugs. Besides, by raising funds to set up oncology hospitals and diabetes hospitals, the company further extends its business to medical services. It plans to build up a medical health service platform, integrating pharmaceutical with medical services, to enhance its capacity for sustainable profitability and management.


Shengjitang has ten production lines in compliance with GMP standards, covering several kinds of products such as granules, tablets, capsules, tinctures, infusion soft bags, small-volume injections, films, raw material drugs, blood glucose meters, healthcare products, etc.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。
推荐阅读

宁波大学附属第一医院完成术锐单孔机器人首例全腔镜一体位输尿管癌根治术

术锐机器人 2024-06-19 18:00

商业模式新探索——术锐®机器人与北京市海淀医院共建科技应用场景

术锐机器人 2024-06-19 18:00

天新药业2023年度每股派0.5元股权登记日为6月25日

智通财经 2024-06-19 17:56

Mailman

共发表文章3245篇

最近内容
查看更多
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

相关公司
查看更多

圣济堂

糖尿病药品研发商

立即沟通

福宁科技

互联网医药医疗解决方案提供商

立即沟通
产业链接
查看更多